[1]阿巴伯克力 ? 乌斯曼 艾克拜尔 ? 艾力.肥胖症与抑郁症相关性的研究进展[J].中华肥胖与代谢病电子杂志,2019,(01):37-40.[doi:DOI:10.3877/cma.j.issn.2095-9605.2019.01.007]
点击复制

肥胖症与抑郁症相关性的研究进展()
分享到:

《中华肥胖与代谢病电子杂志》[ISSN:2095-9605/CN:11-9362]

卷:
期数:
2019年01期
页码:
37-40
栏目:
综述
出版日期:
2019-04-28

文章信息/Info

作者:
阿巴伯克力 ? 乌斯曼 12 艾克拜尔 ? 艾力 12
830001 乌鲁木齐, 新疆医科大学1 ;新疆维吾尔自治区人 民医院微创、疝和腹壁外科
关键词:
肥胖症 抑郁症 相关性
DOI:
DOI:10.3877/cma.j.issn.2095-9605.2019.01.007

参考文献/References:


[1] Arroyo-Johnson C, Mincey K D. Obesity Epidemiology Worldwide[J]. Gastroenterology Clinics of North America, 2016, 45(4): 571-579.
[2] Allison DB, Newcomer JW, Dunn AL, et al. Obesity Among Those with Mental Disorders[J]. American Journal of Preventive Medicine, 2009, 36(4): 341-350.
[3] Scully T. Public health: Society at large[J]. Nature, 2014, 508(7496): S50-S51.
[4] 施慎逊, 陈致宇, 张斌, 等. 全球抑郁症研究最新进展[J]. 中国医师杂志, 2015(z2): 229-232.
[5] Preiss K, Brennan L, Clarke D. A systematic review of variables associated with the relationship between obesity and depression[J]. Obes Rev, 2013, 14(11): 906-918.
[6] Castanon N, Luheshi G, Laye S. Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity[J]. Front Neurosci, 2015, 9:229.
[7] Sharma S, Fulton S. Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry[J]. Int J Obes (Lond), 2013, 37(3): 382-389.
[8] van Reedt DA, Giltay EJ, van Veen T, et al. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use[J]. Acta Psychiatr Scand, 2010, 122(1): 30-39.
[9] Sanchez-Villegas A, Martinez-Gonzalez MA. Diet, a new target to prevent depression?[J]. BMC Med, 2013, 11:3.
[10] Valladolid-Acebes I, Merino B, Principato A, et al. High-fat diets induce changes in hippocampal glutamate metabolism and neurotransmission[J]. Am J Physiol Endocrinol Metab, 2012, 302(4):E396-E402.
[11] Larrieu T, Hilal ML, Fourrier C, et al. Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depressionrelated behaviour through corticosterone secretion[J]. Transl Psychiatry, 2014, 4:e437.
[12] Strekalova T, Evans M, Costa-Nunes J, et al. Tlr4 upregulation in the brain accompanies depression- and anxiety-like behaviors induced by a high-cholesterol diet[J]. Brain Behav Immun, 2015, 48:42-47.
[13] Sun S, Yang S, Mao Y, et al. Reduced cholesterol is associated with the depressive-like behavior in rats through modulation of the brain 5-HT1A receptor[J]. Lipids Health Dis, 2015, 14:22.
[14] Marazziti D, Rutigliano G, Baroni S, et al. Metabolic syndrome and major depression[J]. CNS Spectr, 2014, 19(4):293-304.
[15] Stieg MR, Sievers C, Farr O, et al. Leptin: A hormone linking activation of neuroendocrine axes with neuropathology[J]. Psychoneuroendocrinology, 2015, 51: 47-57.
[16] Diwan AG, Kuvalekar AA, Dharamsi S, et al. Correlation of Serum Adiponectin and Leptin levels in Obesity and Type 2 Diabetes Mellitus[J]. Indian J Endocrinol Metab, 2018, 22(1): 93-99.
[17] Yamada N, Katsuura G, Ochi Y, et al. Impaired CNS leptin action is implicated in depression associated with obesity[J]. Endocrinology, 2011, 152(7): 2634-2643.
[18] Guo M, Lu Y, Garza JC, et al. Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression[J]. Transl Psychiatry, 2012, 2: e83.
[19] Liu J, Guo M, Zhang D, et al. Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity[J]. Proc Natl Acad Sci U S A, 2012, 109(30): 12248-12253.
[20] Yau SY, Li A, Hoo RL, et al. Physical exercise-induced hippocampal neurogenesis and antidepressant effffects are mediated by the adipocyte hormone adiponectin[J]. Proc Natl Acad Sci U S A, 2014, 111(44): 15810-15815.
[21] Wilhelm CJ, Choi D, Huckans M, et al. Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression[J]. Pharmacol Biochem Behav, 2013, 103(3): 643-651.
[22] Gorelick PB. Role of inflflammation in cognitive impairment: results of observational epidemiological studies and clinical trials[J]. Ann N Y Acad Sci, 2010, 1207: 155-162.
[23] Walker AK, Kavelaars A, Heijnen CJ, et al. Neuroinflammation and comorbidity of pain and depression[J]. Pharmacol Rev, 2014, 66(1):80-101.
[24] Wu TY, Liu L, Zhang W, et al. High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior[J]. J Psychiatr Res, 2015, 64: 99-106.
[25] van Heesch F, Prins J, Konsman JP, et al. Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice[J]. Eur J Pharmacol, 2014, 725: 55-63.
[26] Thaler JP, Yi CX, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans[J]. J Clin Invest, 2012, 122(1): 153-162.
[27] van Reedt DA, Vreeburg SA, Giltay EJ, et al. The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression[J]. Psychoneuroendocrinology, 2013, 38(2): 209-218.
[28] Guo M, Lu Y, Garza JC, et al. Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression[J]. Transl Psychiatry, 2012, 2: e83.
[29] Carney RM, Freedland KE, Veith RC. Depression, the autonomic nervous system, and coronary heart disease[J]. Psychosom Med, 2005,67 Suppl 1:S29-S33.
[30] Marazziti D, Rutigliano G, Baroni S, et al. Metabolic syndrome and major depression[J]. CNS Spectr, 2014, 19(4): 293-304.
[31] Carnethon MR, Golden SH, Folsom AR, et al. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998[J]. Circulation, 2003,107(17):2190-2195.
[32] Kreier F, Yilmaz A, Kalsbeek A, et al. Hypothesis: shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome[J]. Diabetes, 2003, 52(11):2652-2656.
[33] Martin KA, Mani MV, Mani A. New targets to treat obesity and the metabolic syndrome[J]. Eur J Pharmacol, 2015, 763(Pt A):64-74.
[34] Zheng P, Wang Y, Chen L, et al. Identification and validation of urinary metabolite biomarkers for major depressive disorder[J]. Mol Cell Proteomics, 2013, 12(1):207-214.
[35] Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, stability and resilience of the human gut microbiota[J]. Nature, 2012, 489(7415):220-230.
[36] Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage[J]. Proc Natl Acad Sci U S A, 2004, 101(44): 15718-15723.
[37] Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers[J]. Nature, 2013, 500(7464): 541-546.
[38] Backhed F, Manchester JK, Semenkovich CF, et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice[J]. Proc Natl Acad Sci U S A, 2007, 104(3): 979-984.
[39] Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest[J]. Nature, 2006, 444(7122): 1027-1031.
[40] Kelly JR, Borre Y, O' B C, et al. Transferring the blues: Depressionassociated gut microbiota induces neurobehavioural changes in the rat[J]. J Psychiatr Res, 2016, 82: 109-118.

相似文献/References:

[1]康建省 李涛 马利锋 张立超 刘金鸽.腹腔镜袖状胃切除术在治疗病态肥胖症中的应用价值[J].中华肥胖与代谢病电子杂志,2016,2(01):17.[doi:10.3877//cma.j.issn.2095-9605.2016.01.004]
 Kang Jiansheng,LiTao,Ma Lifeng,et al.Application value of laparoscopic sleeve gastrectomy in treating morbid obesity[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2016,2(01):17.[doi:10.3877//cma.j.issn.2095-9605.2016.01.004]
[2]林玉芳 廖继武 黄俏庭 潘集阳.肥胖症的精神药物和心理治疗研究进展[J].中华肥胖与代谢病电子杂志,2016,2(01):46.[doi:10.3877//cma.j.issn.2095-9605.2016.01.011]
[3]何肖 胡雷 陈栋.肥胖症与男性不育症相关性的研究进展[J].中华肥胖与代谢病电子杂志,2016,2(01):49.[doi:10.3877//cma.j.issn.2095-9605.2016.01.012]
[4]李延兵.双管齐下:肥胖型2型糖尿病的内科治疗进展[J].中华肥胖与代谢病电子杂志,2015,1(03):113.[doi:10.3877//cma.j.issn.2095-9605.2015.03.001]
[5]邹启荣 李佳阳 彭雪梅.容量控制通气模式和压力控制通气模式对病态肥胖症患者循环功能的影响[J].中华肥胖与代谢病电子杂志,2015,1(03):122.[doi:10.3877//cma.j.issn.2095-9605.2015.03.003]
 Zou Qirong,Li Jiayang,Peng Xuemei..Effects of volume controlled ventilation and pressure controlled ventilation on morbidly obese patients[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2015,1(01):122.[doi:10.3877//cma.j.issn.2095-9605.2015.03.003]
[6]张涛涛 张向文 梁怀祝 赵国华.腹腔镜Roux-en-Y胃旁路术治疗肥胖型2型糖尿病的三年随访研究[J].中华肥胖与代谢病电子杂志,2015,1(03):128.[doi:10.3877//cma.j.issn.2095-9605.2015.03.004]
 Zhang Taotao,Zhang Xiangwen,Liang Huaizhu,et al.Three-year follow-up study of laparoscopic Roux-en-Y gastric bypass for treating obese type 2 diabetes mellitus[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2015,1(01):128.[doi:10.3877//cma.j.issn.2095-9605.2015.03.004]
[7]杨建军 王兵 顾岩.重视肥胖与代谢病外科的卫生经济学管理[J].中华肥胖与代谢病电子杂志,2015,1(03):150.[doi:10.3877//cma.j.issn.2095-9605.2015.03.009]
[8]黄鑫 刘少壮 张光永 胡三元.肥胖症与2型糖尿病的基础研究进展——基于减重手术的探讨[J].中华肥胖与代谢病电子杂志,2016,2(02):61.[doi:10.3877//cma.j.issn.2095-9605.2016.02.001]
[9]李子建 李海龙 陈伟.代谢手术的营养相关问题[J].中华肥胖与代谢病电子杂志,2016,2(02):76.[doi:10.3877//cma.j.issn.2095-9605.2016.02.004]
[10]伍方旭 陈茜 陈伟 张晶晶 周智广 刘威.腹腔镜Roux-en-Y胃旁路术在改善肥胖症患者生活质量中的应用价值[J].中华肥胖与代谢病电子杂志,2016,2(02):90.[doi:10.3877//cma.j.issn.2095-9605.2016.02.007]
 Wu Fangxu,Chen Xi,Chen Wei,et al.Application value of laparoscopic Roux-en-Y gastric bypass in improving the quality of life for obesepatients[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2016,2(01):90.[doi:10.3877//cma.j.issn.2095-9605.2016.02.007]

更新日期/Last Update: 2019-04-28